Berger Mark Stanley 4
4 · Genprex, Inc. · Filed Feb 21, 2024
Insider Transaction Report
Form 4
Genprex, Inc.GNPX
Berger Mark Stanley
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2024-02-18$4.40/sh−1,319$5,804→ 4,806 total
Footnotes (2)
- [F1]Represents shares withheld on February 18, 2024 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan.
- [F2]This total represents the number of shares of Common Stock beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's Common Stock effected as of February 2, 2024.